Clearmind Medicine Inc. (CMND)
NASDAQ: CMND
· Real-Time Price · USD
1.00
-0.02 (-1.96%)
At close: Oct 03, 2025, 3:59 PM
1.02
2.00%
After-hours: Oct 03, 2025, 07:58 PM EDT
-1.96% (1D)
| Bid | 1 |
| Market Cap | 5.46M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -4.83M |
| EPS (ttm) | -0.75 |
| PE Ratio (ttm) | -1.33 |
| Forward PE | n/a |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 1.1 |
| Volume | 66,506 |
| Avg. Volume (20D) | 783,436 |
| Open | 1.00 |
| Previous Close | 1.02 |
| Day's Range | 0.99 - 1.04 |
| 52-Week Range | 0.80 - 2.18 |
| Beta | -1.23 |
| Ex-Dividend Date | n/a |
About CMND
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CMND
Website n/a
2 weeks ago
+19%
Clearmind Medicine shares are trading higher after...
Unlock content with
Pro Subscription
3 months ago
+21.82%
Clearmind Medicine shares are trading higher after the company announced IRB approval for its Phase 1/2a clinical trial for alcohol use disorder at Tel Aviv Sourasky Medical Center.
